Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amel Tobaa"'
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e90426ddcadafd0d3d8e4e3b5d2a08
https://doi.org/10.7759/cureus.32281
https://doi.org/10.7759/cureus.32281
Autor:
Kirtivardhan Vashistha, Amel Tobaa, Mark Doyle, Susan Bartley, Stephen Bailey, Robert W Biederman
Publikováno v:
Circulation. 144
Background: Despite growing demand, TAVR implantation is not free of complications, conduction defects being one of the major barriers to its widespread usage. We sought to evaluate the prognostic implications of interventricular (IVS) and mitral ann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90debddb5e790a052cae536ecef9b099
https://doi.org/10.1161/circ.144.suppl_1.9606
https://doi.org/10.1161/circ.144.suppl_1.9606
Publikováno v:
Journal of Cardiac Failure. 28:S101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22f99b1ece51e48c2029443884c0bc79
https://doi.org/10.1016/j.cardfail.2022.03.257
https://doi.org/10.1016/j.cardfail.2022.03.257
Autor:
Arinze Bosah, Amel Tobaa, Kushani Gajjar, Kartikeya Kashyap, Mithun Chakravarthy, Craig Alpert
Publikováno v:
Journal of Cardiac Failure. 28:S30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61d1bc846e01c0567dd25a5c40eb761d
https://doi.org/10.1016/j.cardfail.2022.03.082
https://doi.org/10.1016/j.cardfail.2022.03.082
Autor:
Adee Elhamdani, Laith Alhuneafat, Amel Tobaa, Mian Tanveer Ud Din, Arinze Bosah, Kirtivardhan Vashistha, Mark Doyle, Adnan Khalif, Indu G. Poornima
Publikováno v:
Journal of the American College of Cardiology. 79:990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::029dbc52c9ad431b2c6360970742ed0c
https://doi.org/10.1016/s0735-1097(22)01981-7
https://doi.org/10.1016/s0735-1097(22)01981-7
Publikováno v:
Journal of the American College of Cardiology. 75:3346
Anthracyclines are a common class of chemotherapeutics used to treat a variety of malignancies. These agents exhibit dose-dependent cardiotoxicity and are relatively contraindicated for patients with preexisting LV systolic dysfunction. Herein, we pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c413cbcc32c7a683b5feb8c58fec6475
https://doi.org/10.1016/s0735-1097(20)33973-5
https://doi.org/10.1016/s0735-1097(20)33973-5